Nocimed is now Aclarion.

Advancing the care of patients suffering from chronic lower back pain

by delivering noninvasive, evidence-based, SaaS solutions to help physicians deliver personalized treatment plans to support improved clinical outcomes and help patients return to a life without back pain.

Leadership Team

Meet the people improving the way doctors
understand spinal disc pain.

Jeff Thramann, MD
Executive Director, Executive Chairman, and Director
Jeff Thramann, MD
Executive Director, Executive Chairman, and Director

Jeff Thramann is the Executive Chairman and Director at Aclarion. He oversees strategic initiatives, capitalization, and governance at the company. Dr. Thramann is a serial entrepreneur who has founded consumer and medtech companies such as Auddia Inc. (NASDAQ: AUUD,) Lanx, LLC (sold to Biomet Inc. November 2013,) ProNerve, LLC. (sold to Waud Capital Partners 2012,) and U.S. Radiosurgery (sold to Alliance Healthcare Services (NASDAQ: AIQ) April 2011.)

Dr. Thramann is also an accomplished neurosurgeon who founded and was a senior partner of Boulder Neurosurgical Associates, a neurosurgical practice serving Boulder County, Colorado. Dr. Thramann is the named inventor on over 100 U.S. and international issued and pending patents. He completed his neurosurgical residency and complex spinal reconstruction fellowship at the Barrow Neurological Institute in Phoenix, AZ and is a graduate of Cornell University Medical College in New York City. He also earned his Bachelor of Science degree in electrical engineering management at the U. S. Military Academy in West Point, NY.

Brent Ness
Chief Executive Officer, President, and Director
Brent Ness
Chief Executive Officer, President, and Director

Mr. Ness became the Chief Executive Officer of Aclarion in September 2021. Mr. Ness has over 25 years of medical device and healthcare technology experience and has held various executive and senior leadership positions, including recently as CCO of Cleerly, Inc. At Cleerly, Mr. Ness built key industry partnerships with Canon Inc. to drive adoption of their AI-enabled cardiology solution. Previously, Mr. Ness was also the Chief Operating Officer of Mighty Oak Medical (“Mighty Oak”) whose principal products progressed from pre-FDA clearance through an international full market launch of their platform called FIREFLY.

Mr. Ness was also Chief Commercial Officer of HeartFlow, Inc., (“Heartflow”). Mr. Ness led Hearflow from pre-FDA clearance through a global expansion of early adopter sites. He also served as President of ProNerve, LLC, (“ProNerve) where he led a roll up of the highly fragmented Interoperative Nerve Monitoring Industry.

 

Mr. Ness has also held senior leadership roles at Medtronic, GE Healthcare, and Philips North America. He is a graduate of the University of North Dakota with a BS in Business Administration and received his MBA for the University of Colorado.

Ryan Bond
Chief Strategy Officer
Ryan Bond
Chief Strategy Officer

Mr. Bond is the Chief Strategy Officer at Aclarion. Prior to his current role, he was the Vice President of Business Development, where he led business development, sales and marketing including a limited commercial launch of Aclarion’s cloud-based SaaS with early adopters in the US, EU, and UK.

Prior to his time at Aclarion, Mr. Bond was Director, Healthcare Solutions at NuVasive, a company in the global spine market. While at NuVasive, he led several strategic initiatives involving strategic partnerships, channel development, pricing, contracting, and sales training. Mr. Bond also worked with Accelero Health Partners (“Accelero”), a consulting firm focused on musculoskeletal service line development that wasacquired by Zimmer Holdings.

Mr. Bond serves on an Advisory Board to the College of Business at Ohio University, where he earned a Bachelor of Science Degree in Engineering from the Russ College of Engineering and Technology.

John Lorbiecki
Chief Financial Officer
John Lorbiecki
Chief Financial Officer

Mr. Lorbiecki joined Aclarion in October 2021 as the Chief Financial Officer. He has over 25 years of financial management and operational experience which includes serving as the divisional CFO for two business units within Medtronic, Inc. Mr. Lorbiecki has also held senior financial leadership and consulting roles at Strategic Finance Solutions LLC, a financial consulting company, Fusion Robotics LLC, and Honeybee Robotics. He also served as Chief Operating Officer at Colorado Therapeutics LLC, a medical startup focused on innovative biologic soft tissue repair products where he was instrumental in completing the relocation of the company headquarters and increasing manufacturing capacity.

At Medtronic, he led sales operations, including pricing and contracting, for the Cardiac Surgery Division and held several corporate financial leadership roles. Mr. Lorbiecki has a Bachelor’s Degree in Economics from the University of St. Thomas where he graduated magna cum laude and an MBA from the University of Chicago Booth School of Business.

Board of Directors

Jeff Thramann, MD
Executive Director, Executive Chairman, and Director
Jeff Thramann, MD
Executive Director, Executive Chairman, and Director

Jeff Thramann is the Executive Chairman and Director at Aclarion. He oversees strategic initiatives, capitalization, and governance at the company. Dr. Thramann is a serial entrepreneur who has founded consumer and medtech companies such as Auddia Inc. (NASDAQ: AUUD,) Lanx, LLC (sold to Biomet Inc. November 2013,) ProNerve, LLC. (sold to Waud Capital Partners 2012,) and U.S. Radiosurgery (sold to Alliance Healthcare Services (NASDAQ: AIQ) April 2011.)

Dr. Thramann is also an accomplished neurosurgeon who founded and was a senior partner of Boulder Neurosurgical Associates, a neurosurgical practice serving Boulder County, Colorado. Dr. Thramann is the named inventor on over 100 U.S. and international issued and pending patents. He completed his neurosurgical residency and complex spinal reconstruction fellowship at the Barrow Neurological Institute in Phoenix, AZ and is a graduate of Cornell University Medical College in New York City. He also earned his Bachelor of Science degree in electrical engineering management at the U. S. Military Academy in West Point, NY.

Brent Ness
Chief Executive Officer, President, and Director
Brent Ness
Chief Executive Officer, President, and Director

Mr. Ness became the Chief Executive Officer of Aclarion in September 2021. Mr. Ness has over 25 years of medical device and healthcare technology experience and has held various executive and senior leadership positions, including recently as CCO of Cleerly, Inc. At Cleerly, Mr. Ness built key industry partnerships with Canon Inc. to drive adoption of their AI-enabled cardiology solution. Previously, Mr. Ness was also the Chief Operating Officer of Mighty Oak Medical (“Mighty Oak”) whose principal products progressed from pre-FDA clearance through an international full market launch of their platform called FIREFLY.

Mr. Ness was also Chief Commercial Officer of HeartFlow, Inc., (“Heartflow”). Mr. Ness led Hearflow from pre-FDA clearance through a global expansion of early adopter sites. He also served as President of ProNerve, LLC, (“ProNerve) where he led a roll up of the highly fragmented Interoperative Nerve Monitoring Industry.

Mr. Ness has also held senior leadership roles at Medtronic, GE Healthcare, and Philips North America.

David Neal
Founder, SC Capital 1 LLC.
David Neal
Founder, SC Capital 1 LLC.

Mr. Neal has been on the Aclarion Board of Directors since September 2016. He is the founder and a current member of SC Capital 1 LLC, a securitized LLC formed to invest in breakthrough medical technologies and therapies. He is also a partner of Frontier Wealth Enterprises, LLC a financial services firm providing advice-based financial services to high net-worth families. He has held various positions with UBS, including Portfolio Manager and Regional Office Manager in Wichita Kansas. He was on the Hutchinson Regional Medical Center Board of Directors for 9 years and currently sits on the boards of The Cosmosphere, a world-class space museum & STEM education center, and the Hutchinson Community Foundation.

In 2007, Mr. Neal and his wife, Karin, started the John & Michael Neal Foundation for Cancer Research to raise money to help fund research for cancer research and breakthrough medical technologies across the globe. He holds a Bachelor of Sport Science degree from the University of Kansas and a Master of Management Science degree from the John Cook School of Business at Saint Louis University.

Bill Wesemann
Director, LivePerson Inc., Stationhead Inc., Mylio Inc.
Bill Wesemann
Director, LivePerson Inc., Stationhead Inc., Mylio Inc.

Mr. Wesemann has been on the Aclarion Board of Directors since 2016. Mr. Wesemann has been an independent businessman and investor since June 2002. Prior to 2002 his experience included serving in chief executive, sales leadership, and advisory roles at various technology companies. He has been a director of LivePerson (Nasdaq: LPSN), a global technology company that develops conversational commerce and AI software. He is also a director of Stationhead, Inc., a consumer social audio platform; and a director of Mylio, Inc, a photo management company. Mr. Wesemann received a B.A. from Glassboro State College (Rowan University).

Amanda Sequira
SVP, Clinical, Quality, and Regulatory, ViewRay Inc.
Amanda Sequira
SVP, Clinical, Quality, and Regulatory, ViewRay Inc.

Ms. Sequira is currently the Senior Vice President of Clinical, Quality and Regulatory at ViewRay, Inc. (Nasdaq: “VRAY”), a healthcare company that integrates real time MRI imaging of tumors with the delivery of high dose radiation for improved treatment accuracy. She brings 20 years of experience in the medical device space to the Aclarion board. She was the Head of Regulatory with the Image Guided Therapy Devices and Systems divisions of Philips and the Senior Director and Vice President of Clinical and Regulatory with The Spectranetics Corp., (now part of Philips).

From 2003 to 2010 she was Manager, and then Director of Regulatory of AGA Medical Corp (now part of Abbott). Prior to these roles, she worked as a Regulatory Specialist with Vascular Solutions and as a Chemist with GE – Osmonics. She holds a Master’s of Science in Regulatory from Northeastern University and a Bachelor’s of Science in Chemistry from the University of Minnesota.

Steve Deitsch
CFO, Paragon 28 Inc.
Steve Deitsch
CFO, Paragon 28 Inc.

Steve Deitsch is the CFO of Paradigm 28, a medical device company focused on surgical implants for the foot and ankle. Steve has extensive strategic, operational, and financial executive and senior leadership experience at both publicly traded and privately held companies, including BioScrip, Inc. (now part of Option Care Health, Inc. (NASDAQ: BIOS),) Coalfire, Inc., Zimmer Biomet Spine, Lanx (acquired by Biomet October 2013.) He also held various senior financial leadership roles at Zimmer Holdings, Inc. (now part of Zimmer Biomet, Inc.)

Steve is current on the Board of Directors at Green Sun Medical, a privately held medical device company, and a board member and audit committee chair of Auddia Inc. (NASDAQ: AUUD).

Scott Breidbart, MD
Advisor/Consultant, Redesign Health Inc., Stellar Health
Scott Breidbart, MD
Advisor/Consultant, Redesign Health Inc., Stellar Health

Dr. Scott Breidbart has an extensive background in health care delivery. He is an advisor to Redesign Health and a consultant for Stellar Health. Redesign Health is a mission-driven innovation platform that launches transformative healthcare companies. Stellar Health is a healthcare technology company focused on enabling success across the value-based care continuum by bridging the incentive gap between providers and payors.

Dr. Breidbart has an over 20 year history in managed care, most recently as the Chief Medical Officer of Affinity Health Plans. He has also served as Chief Medical Officer of Solera Health, the Chief Clinical Officer of Emblem Health, the Chief Medical Officer of Empire BlueCross BlueShield, and has held various roles in medical management for HealthNet. Dr. Breidbart practiced pediatric endocrinology for ten years on the faculty of New York Medical College. He is Board Certified in Pediatrics and Pediatric Endocrinology and is licensed to practice medicine in NY. He holds a BA in Mathematics from Yale, an MD from Columbia, and an MBA from Pace University.

Medical Advisory Board

Robert K Eastlack, MD
Head of the Division of Spine Surgery, Scripps Clinic
Robert K Eastlack, MD
Head of the Division of Spine Surgery, Scripps Clinic

Dr. Eastlack is currently Head of the Division of Spine Surgery at Scripps Clinic, Director of Clinical Research, and Co-Director for the Spine Fellowship Training Program at Scripps Clinic and the San Diego Spine Foundation in San Diego, CA. He is President of the San Diego Orthopedic Society, and a member of the International Spine Study Group, focused on adult deformity and minimally invasive research in spine surgery. He is an active fellow in the Scoliosis Research Society and is a director of the San Diego Spine Foundation. Dr. Eastlack has published over 100 articles and over 175 studies/abstracts, in addition to contributing chapters to 11 books. He received his fellowship training in spine surgery from Mayo Clinic, after completing an orthopedic surgery residency and research fellowship at UC San Diego. He obtained his medical degree from Baylor College of Medicine and graduated from Stanford University after studying human biology with a focus in neurophysiology.

Lawrence Tanenbaum, MD
VP, CTO, and Director of Advanced Imaging, RadNet Inc.
Lawrence Tanenbaum, MD
VP, CTO, and Director of Advanced Imaging, RadNet Inc.

Dr. Tanenbaum is currently Vice President, Chief Technology Officer and Director of Advanced Imaging at RadNet Inc. having come from Icahn School of Medicine at Mount Sinai in New York where he attended in Neuroradiology and served as an Associate Professor of Radiology, Director of MRI, CT and Outpatient / Advanced Imaging Development since 2008. Prior to that he spent over 20 years in the private practice of Radiology at the JFK Medical Center / New Jersey Neuroscience Institute as Director of MRI, CT and Neuroradiology.

Dr. Tanenbaum is a senior member of the American Society of Neuroradiology and long-term member of the Radiological Society of North America. He is a member of the Roster of Distinguished Scientific Advisors of the RSNA as well as several panels and committees of the American College of Radiology including the Expert Panel on Neuroimaging and the CPI / Neuroradiology Expert Review Panel.

He has authored over 100 scholarly and peer reviewed articles which have been cited over 1000 times, continues to chair educational and academic meetings and has delivered close to 2000 invited lectures around the world.

Scientific Advisory Board

Professor Jeffrey Lotz, PhD
Endowed Chairs of Orthopedic Surgery and Vice Chair of Orthopedic Research and UCSF
Professor Jeffrey Lotz, PhD
Endowed Chairs of Orthopedic Surgery and Vice Chair of Orthopedic Research and UCSF

Dr. Lotz is the David S. Bradford M.D. Endowed Chair in Orthopedic Surgery and Vice Chair of Orthopedic Research at UCSF. He has led the Orthopedic Tissue Engineering Laboratory at UCSF since 1992 and is principal investigator of one of the three Mechanistic Research Centers funded through the NIH Back Pain Consortium (BACPAC) Research Program (under NIH HEAL). Dr. Lotz is also director of two other research centers, including the NIH/NIDCR-funded Center for Dental, Oral and Craniofacial Tissue and Organ Regeneration (C-DOCTOR); and the NSF-funded Industry/University Cooperative Research Center (CDMI).

Dr. Lotz work focuses on identifying mechanisms of disc degeneration, developing novel diagnostics and therapies for low back pain, and the biomechanics of spinal instrumentation, with over 200 peer-reviewed publications on these topics. Dr. Lotz earned a doctorate degree in Medical Engineering from the Harvard/MIT Division of Health Sciences and Technology, a Master of Science Degree in Mechanical Engineering Design from Stanford University, and Bachelor of Science in Mechanical Engineering from UC Berkeley.

Request Info or Schedule a Demo

This field is for validation purposes and should be left unchanged.

Aclarion
951 Mariners Island Blvd #300
San Mateo, CA 94404

info@aclarion.com

(650) 241-1741